6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide
C22H21N7O2 — CID 165415220
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide
6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide (PubChem CID 165415220) has the molecular formula C22H21N7O2 and a molecular weight of 415.46 g/mol. Its IUPAC name is 6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide.
Molecular Properties
| Compound Name | 6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|---|---|
| PubChem CID | 165415220 |
| Molecular Formula | C22H21N7O2 |
| Molecular Weight | 415.46 g/mol |
| Exact Mass | 415.18 |
| IUPAC Name | 6-(methoxymethyl)-N-[3-(1-methylpyrazol-3-yl)phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
| SMILES | COCc1ccc(Nc2cncnc2)c(C(=O)Nc2cccc(-c3ccn(C)n3)c2)n1 |
| InChI | InChI=1S/C22H21N7O2/c1-29-9-8-19(28-29)15-4-3-5-16(10-15)27-22(30)21-20(7-6-17(26-21)13-31-2)25-18-11-23-14-24-12-18/h3-12,14,25H,13H2,1-2H3,(H,27,30) |
| InChIKey | ZZRDSAAUJLZYPT-UHFFFAOYSA-N |
| XLogP | 3.41 |
| TPSA | 106.85 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.46 |
| LogP ≤ 5 | 3.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165415220 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.